SS
Séverine SIGRIST
DEFYMED
General manager, innovation, medtech/biotech, outlicensing, strategy, investment
Description
With a PhD in life sciences, Séverine Sigrist directed the research activity of the European Diabetes Study Centre for 10 years before creating Defymed in 2011, a company that develops and markets innovative implantable medical devices. She chaired the Biovalley France competitiveness cluster for 6 years, is an elected external representative on the board of the University of Strasbourg and has been President of Alsace Creation since September 2021.
Loading